Penn State Health Hematology/Oncology at Penn State Children's Hospital provides comprehensive care to infants, children, adolescents and young adults with a variety of healthcare needs. Care is provided using a multidisciplinary team with the expertise of many other pediatric specialists, and with the patient and family being at the center of the healthcare team.

Our pediatric Hematology service cares for children with all types of blood disorders including sickle cell anemia, hemophilia, and bleeding and thrombotic disorders. The hematology consult clinic deals with difficult diagnostic or therapeutic problems. 

Our Oncology service provides state-of-the-art care for children with every type of cancer including hematologic malignancies, brain tumors, and all solid tumors.  The Division of Pediatric Hematology/Oncology participates in clinical trials through the Children's Oncology Group (COG) and the Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC). The Pediatric Stem Cell Transplant program offers state-of-the-art comprehensive transplant services.

The Division of Pediatric Hematology/Oncology faculty conduct cutting-edge basic, translational, and clinical cancer and hematology research aimed at understanding the fundamental mechanisms that lead to malignancy, and developing novel treatment strategies for childhood malignancy. Research is supported by the National Institutes of Health, the Four Diamonds Fund, the St. Baldrick's Foundation, and other philanthropic organizations.

The Four Diamonds Pediatric Cancer Research Center was established in 1999 and is now supported by greater than thirty million dollars in endowments including the Penn State IFC/Panhellenic Dance Marathon Chair, the Christopher Millard Endowed Chair in Pediatric Oncology, the Experimental Therapeutics Program, and the Molecular Oncology Program.